Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
March 4, 2009

Nanogen Licenses Technology to Quest for In Vitro Diagnostic Testing

  • Quest Diagnostics obtained rights to use and sell products and services incorporating Nanogen’s MGB (minor groove binder) Probe technology. According to the end-user license agreement, Quest will pay an up-front fee and royalties on tests sold using this technology. Quest will be able to use this platform in human in vitro diagnostic testing.

Related content

  • You’re all set! Thank you for subscribing to GEN Highlights.